medigraphic.com
SPANISH

Annals of Hepatology

Órgano Oficial de la Asociación Mexicana de Hepatología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 3

<< Back Next >>

Ann Hepatol 2014; 13 (3)

Inflammation is not the cause of an elevated serum ferritin in non-alcoholic fatty liver disease

Beaton MD, Chakrabarti S, Adams PC
Full text How to cite this article

Language: English
References: 6
Page: 353-356
PDF size: 123.01 Kb.


Key words:

non-alcoholic steatohepatitis, haemochromatosis, fatty liver, iron overload.

ABSTRACT

Background. In non-alcoholic fatty liver disease (NALFD), it has often been assumed that an elevation in serum ferritin is likely related to inflammation rather than iron overload. Material and methods. Patients referred with NAFLD were entered into a clinical study of phlebotomy therapy. A liver biopsy with liver iron concentration was done at entry and 6 months after phlebotomy (n = 56) until the patient had a low serum ferritin or developed anemia. Serum ferritin was compared to liver iron concentration, ESR, CRP, BMI and grade of inflammation on liver biopsy. Results. Iron removed by phlebotomy in NAFLD correlated with the decrease in serum ferritin (r = 0.57, p = 0.0014) and liver iron concentration (r = 0.57, p = 0.0013). There was no significant correlations between serum ferritin and ESR, CRP or grade of liver inflammation. Conclusions. Serum ferritin is related to liver iron storage in NAFLD and decreasing body iron stores by phlebotomy is reflected by an appropriate decrease in serum ferritin. Inflammation is not the cause of the elevated serum ferritin in fatty liver disease.


REFERENCES

  1. Chandok N, Minuk G, Wengiel M, Uhanova J. Serum ferritin levels do not predict the stage of underlying non-alcoholic fatty liver disease. J Gastrointestin Liver Dis 2012; 21: 53-8.

  2. Beaton M, Chakrabarti S, Levstik M, Speechley M, Marotta P, Adams P. Phase II Clinical Trial of phlebotomy therapy for non-alcoholic liver disease. Aliment Pharmacol Ther 2013; 37: 720-9.

  3. Crook MA. Hyperferritinaemia; laboratory implications. Ann Clin Biochem 2012; 49: 211-3.

  4. Chandok N, Minuk G, Wengiel M, Uhanova J. Serum ferritin levels do not predict the stage of underlying non-alcoholic fatty liver disease. J Gastrointestin Liver Dis 2012; 21: 53-8.

  5. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986; 6: 24-9.

  6. Adams PC, Powell LW, Halliday JW. Isolation of a human hepatic ferritin receptor. Hepatology 1988; 8: 719-21.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ann Hepatol. 2014;13